Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT04771390 2021-08-25

Study to Compare How the Body Absorbs, Distributes and Excretes the Drug Selitrectinib (BAY2731954) Given as Two Different Tablet Formulations or as Liquid Formulations Including the Effect of Food on the Absorption, Distribution or Excretion of the Different Formulations in Healthy Participants

Phase 1 Completed

52 enrolled

Other solid neoplasm

Solid Tumors Harboring NTRK Fusion

NCT01976741 2021-05-06

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Phase 1 Completed

168 enrolled 59 charts

GenitourinaryHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms

NCT04675021 2021-01-26

Absolute Bioavailability and ADME Study of Savolitinib in Healthy Male Subjects

Phase 1 Completed

8 enrolled

Tumor-Agnostic

Neoplasms

NCT02239679 2018-08-24

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

Phase 2 Completed

166 enrolled 79 charts

Dermatologic

Keratosis, Actinic

NCT02632110 2018-01-18

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

Phase 2 Completed

137 enrolled 58 charts

Dermatologic

Keratosis, Actinic

NCT03024060 2017-11-07

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Phase 3 Withdrawn

Dermatologic

Keratosis, Actinic

NCT00711958 2017-09-05

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

Phase 3 Completed

114 enrolled 10 charts

Classical hematology

Anemia

NCT02209012 2016-09-23

Twelve Month Follow-Up of CP0108

Completed

206 enrolled

Dermatologic

Keratosis, Actinic

NCT01314599 2015-11-05

Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome

Phase 1 Completed

45 enrolled

Other hematologic neoplasm

Leukemia

NCT02137785 2015-09-16

Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities

Phase 3 Completed

269 enrolled 61 charts

Dermatologic

Keratosis, Actinic

NCT00210080 2015-09-04

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

Phase 3 Completed

700 enrolled

Thoracic

Lung Neoplasms

Clinical Trials

MK-3475-D20

EpiTALY

Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma

Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors

KEYNOTE F19

Study to Compare How the Body Absorbs, Distributes and Excretes the Drug Selitrectinib (BAY2731954) Given as Two Different Tablet Formulations or as Liquid Formulations Including the Effect of Food on the Absorption, Distribution or Excretion of the Different Formulations in Healthy Participants

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Absolute Bioavailability and ADME Study of Savolitinib in Healthy Male Subjects

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

Twelve Month Follow-Up of CP0108

Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome

Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)